2.6
2023

Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy

SUMMARY

Mastocytosis is a clonal disease derived from hematopoietic bone marrow progenitor cells.
Clinical manifestations of the disease vary greatly depending on tissue involvement. Omalizumab is a recombinant humanized monoclonal anti-IgE antibody licensed in the treatment of asthma with increasing reports of clinical efficiency in other allergic diseases. We describe a case of a patient with mastocytosis responsive clinically and patho-physiologically after anti-IgE treatment.

Table of Content: Vol. 45 (No. 2) 2013 March

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024